STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug

Neurocrine Biosciences' rare disease drug is facing growing safety concerns from patient advocates and experts.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.